- Home
- SMSI vs PULM Comparison
SMSI vs PULM Comparison
Compare SMSI & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMSI
- PULM
- Stock Information
- Founded
- SMSI 1982
- PULM 2003
- Country
- SMSI United States
- PULM United States
- Employees
- SMSI N/A
- PULM N/A
- Industry
- SMSI Computer Software: Prepackaged Software
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- SMSI Technology
- PULM Health Care
- Exchange
- SMSI Nasdaq
- PULM Nasdaq
- Market Cap
- SMSI 15.3M
- PULM 18.3M
- IPO Year
- SMSI 1995
- PULM N/A
- Fundamental
- Price
- SMSI $0.77
- PULM $4.90
- Analyst Decision
- SMSI Strong Buy
- PULM
- Analyst Count
- SMSI 1
- PULM 0
- Target Price
- SMSI $5.00
- PULM N/A
- AVG Volume (30 Days)
- SMSI 130.5K
- PULM 10.1K
- Earning Date
- SMSI 11-12-2025
- PULM 11-07-2025
- Dividend Yield
- SMSI N/A
- PULM N/A
- EPS Growth
- SMSI N/A
- PULM N/A
- EPS
- SMSI N/A
- PULM N/A
- Revenue
- SMSI $18,658,000.00
- PULM $369,000.00
- Revenue This Year
- SMSI N/A
- PULM N/A
- Revenue Next Year
- SMSI $59.48
- PULM $134.88
- P/E Ratio
- SMSI N/A
- PULM N/A
- Revenue Growth
- SMSI N/A
- PULM N/A
- 52 Week Low
- SMSI $0.60
- PULM $1.96
- 52 Week High
- SMSI $1.95
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- SMSI 57.55
- PULM 45.99
- Support Level
- SMSI $0.71
- PULM $4.70
- Resistance Level
- SMSI $0.76
- PULM $5.19
- Average True Range (ATR)
- SMSI 0.04
- PULM 0.16
- MACD
- SMSI 0.01
- PULM 0.05
- Stochastic Oscillator
- SMSI 63.04
- PULM 46.30
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).